Centre National De La Recherche Scientifique

Sorbonne Université

Biophytis

Institut Pasteur

Institut National De La Sante Et De La Recherche Medicale

Mathilde Latil

René Lafont

Stanislas Veillet

Pierre Dilda

Fabrice Bruno Chretien

Shahragim Tajbakhsh

Jose-Alain Sahel

José-Alain Sahel

Onnik Agbulut

Serge Camelo

Elodie Monteiro

Valérie Fontaine

Louis Guibout

Christine Balducci

Maria Serova

Laurence Dinan

Fabrice Chrétien

Disclosed are 20-hydroxyecdysone and the derivatives thereof, intended for use in the treatment of a neuromuscular disease such as spinal muscular atrophy or amyotrophic lateral sclerosis, or more particularly in the treatment of a specific disorder of the motor neurons causing alterations in the muscular function occurring in the context of these neuromuscular diseases.

Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases

Disclosed is chemical compounds C that are derivatives of norbixin and have tropism for the eye, and are intended to be used in the treatment of eye diseases in mammals, in particular in the context of altering the retinal pigment epithelium and more particularly in the context of age-related macular degeneration (AMD) and Stargardt's disease.

Chemical compounds targeting the eye and use thereof in the treatment of eye diseases

The invention relates to 20-hydroxyecdysone and the derivatives thereof, for use in the treatment of genetic myopathies.

Use of 20-hydroxyecdysone and the derivatives thereof in the treatment of myopathies

The present invention relates to methods for obtaining stem cells from mammalian cadavers, methods for obtaining or purifying stem cells from a sample likely to contain non-stem cells, methods of regeneration of injured tissues and methods of treatment.

Methods for obtaining stem cells

Growing community of inventors

Paris, France

Mathilde Latil